Business
Tech Companies Face Financial Challenges
Hims & Hers stock fell sharply after reporting a first-quarter loss and weak earnings guidance. The company also reached a deal with Novo Nordisk to sell its GLP-1 weight loss drug Wegovy on its platform.
Coverage timeline — 2 articles
CNBC
U.K.-based Graphcore is developing AI chips and systems and was acquired by the Japanese giant in 2024.
2026-05-12 11:00 UTC
CNBC
Hims & Hers reached a deal with Novo Nordisk in March to sell its GLP-1 weight loss drug Wegovy on its platform.
2026-05-12 11:05 UTC